CAIRDAC
PrivateLast Round
Series A
Mar 31, 2022
Total Funding Raised
$18.9M
Company Overview
CAIRDAC is a medical devices company developing ALPS (Autonomous Leadless Pacing System), a self-sustainable leadless pacemaker that harvests kinetic energy from the heart to power itself.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Health IoT, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CAIRDAC Comparables
Compare CAIRDAC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abbott Laboratories | 82% | |
| Celtro GmbH | 78% | |
| Medtronic | 72% | |
CAIRDAC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 31, 2022 |
Key People
Founding team and executive leadership
CAIRDAC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 10, 2025
Grew 16% QoQ, from 31 to 36 employees.
- Jul 9, 2024
Grew 18% QoQ, from 28 to 33 employees.
CAIRDAC Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CAIRDAC's valuation, stock price, and market status.